Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Droxidopa

23651-95-8C9H11NO5213.189 g/mol

A serine derivative that is L-serine substituted at the β-position by a 3,4-dihydroxyphenyl group. A prodrug for noradrenalone, it is used for treatment of neurogenic orthostatic hypotension — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number23651-95-8ChEBI ↗
Molecular formulaC9H11NO5ChEBI ↗
Molar mass213.189 g/molChEBI ↗
Monoisotopic mass213.06372 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:31524ChEBI ↗

Cross-source molecular data

PubChem
Molar mass213.19 g/molPubChem ↗
Exact mass213.06372245 DaPubChem ↗
Computed XLogP-3.2PubChem ↗
Topological polar surface area (Ų)124PubChem ↗
H-bond donors5PubChem ↗
H-bond acceptors6PubChem ↗
Rotatable bonds3PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
droxidopa
(betaR)-beta,3-dihydroxy-L-tyrosine
QXWYKJLNLSIPIN-JGVFFNPUSA-N
N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1
InChI=1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1

Names & synonyms

(betaR)-beta,3-dihydroxy-L-tyrosineDopsdroxidopumNorthera

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

cardiovascular drugantihypertensive agentantiparkinson drugprodrugvasoconstrictor agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00469067 mol

Uses 213.189 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 9 atoms
50.71%
O
Oxygen · 5 atoms
37.52%
N
Nitrogen · 1 atom
6.57%
H
Hydrogen · 11 atoms
5.20%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa. ↗Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2010 Jun · PMID 20063034
JP2005247828 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
NZ579368 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US2008221170 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:31524

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 92974 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.